Daewoong Pharmaceutical Co., Ltd (KRX:069620)
132,800
-3,700 (-2.71%)
At close: Oct 2, 2025
Daewoong Pharmaceutical Market Cap
Daewoong Pharmaceutical has a market cap or net worth of 1.52 trillion as of October 6, 2025. Its market cap has decreased by -5.90% in one year.
Market Cap
1.52T
Enterprise Value
2.25T
Revenue
1.49T
Ranking
n/a
PE Ratio
20.27
Stock Price
132,800.00
Market Cap Chart
Since March 12, 2003, Daewoong Pharmaceutical's market cap has increased from 131.88B to 1.52T, an increase of 1,054.30%. That is a compound annual growth rate of 11.44%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 2, 2025 | 1,522.28B | 4.67% |
Dec 30, 2024 | 1,454.39B | 8.22% |
Dec 28, 2023 | 1,343.93B | -23.40% |
Dec 29, 2022 | 1,754.47B | 7.09% |
Dec 30, 2021 | 1,638.24B | -7.75% |
Dec 30, 2020 | 1,775.84B | 25.14% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 71.81T |
Celltrion | 38.64T |
ALTEOGEN | 25.22T |
Yuhan | 8,969.60B |
SK Biopharmaceuticals | 8,144.58B |
Peptron | 7,006.86B |
PharmaResearch | 5,714.31B |
LigaChem Biosciences | 5,545.53B |